since left ventricular hypertrophy may be an important determinant of outcome in hypertension , the long-term effects of arterial vasodilation with hydralazine on left ventricular mass and function were compared with those of an alternative third-line drug , the alpha1 blocker prazosin , in patients still hypertensive despite combined diuretic and beta blocker therapy .
C1371278
arterial vasodilation
C0020223
hydralazine